Search
Descriptor English: Antifibrinolytic Agents
Descriptor Spanish: Antifibrinolíticos
Descriptor antifibrinolíticos
Entry term(s) agente antifibrinolítico
agentes antifibrinolíticos
antifibrinolisina
antifibrinolisinas
antifibrinolítico
antiplasmina
antiplasminas
inhibidores de la plasmina
Scope note: Sustancias que previenen la fibrinólisis o lisis de un coágulo de sangre o un trombo. Se conocen varias antiplasminas endógenas. Estos fármacos se utilizan para controlar las hemorragias masivas y otros trastornos de la coagulación.
Descriptor Portuguese: Antifibrinolíticos
Descriptor French: Antifibrinolytiques
Entry term(s): Agent, Antifibrinolytic
Agents, Antifibrinolytic
Antifibrinolysin
Antifibrinolysins
Antifibrinolytic
Antifibrinolytic Agent
Antifibrinolytics
Antiplasmin
Antiplasmins
Inhibitor, Plasmin
Inhibitors, Plasmin
Plasmin Inhibitor
Plasmin Inhibitors
Tree number(s): D27.505.519.421.500
D27.505.954.502.270.463.091
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000933
Scope note: Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders.
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Public MeSH Note: 66
History Note: 66
DeCS ID: 941
Unique ID: D000933
NLM Classification: QV 195
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1966/01/01
Date of Entry: 1999/01/01
Revision Date: 2020/05/27
Antifibrinolytic Agents - Preferred
Concept UI M0001393
Scope note Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders.
Preferred term Antifibrinolytic Agents
Entry term(s) Agent, Antifibrinolytic
Agents, Antifibrinolytic
Antifibrinolysin
Antifibrinolysins
Antifibrinolytic
Antifibrinolytic Agent
Antifibrinolytics
Plasmin Inhibitors - Narrower
Concept UI M0001394
Preferred term Plasmin Inhibitors
Entry term(s) Antiplasmin
Antiplasmins
Inhibitor, Plasmin
Inhibitors, Plasmin
Plasmin Inhibitor



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey